Condition
Common Bile Duct Stricture
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed3
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05945797Not ApplicableCompleted
Effects of Dexamethasone on Common Bile Duct Cannulation Time
NCT04503291Not ApplicableUnknownPrimary
Comparison Between Transpapillary and Suprapapillary Metal Stent
NCT05395013CompletedPrimary
Efficacy and Safety of Plastic, Covered and Uncovered Self-expandable Metal Stents in the Treatment of Malignant Biliary Obstructions (NEOSTENT)
NCT01221311Not ApplicableCompletedPrimary
Covered Metallic Stents for First-Line Treatment of Benign Bile Duct Strictures
Showing all 4 trials